133 related articles for article (PubMed ID: 8010988)
1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced thymic atrophy and lymphocyte stem cell alterations by mechanisms independent of the estrogen receptor.
Frazier DE; Silverstone AE; Gasiewicz TA
Biochem Pharmacol; 1994 Jun; 47(11):2039-48. PubMed ID: 8010988
[TBL] [Abstract][Full Text] [Related]
2. The thymus does not mediate 2,3,7,8-tetrachlorodibenzo-p-dioxin-elicited alterations in bone marrow lymphocyte stem cells.
Frazier DE; Silverstone AE; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Feb; 124(2):242-7. PubMed ID: 8122269
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fine JS; Gasiewicz TA; Silverstone AE
Mol Pharmacol; 1989 Jan; 35(1):18-25. PubMed ID: 2783621
[TBL] [Abstract][Full Text] [Related]
4. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fine JS; Silverstone AE; Gasiewicz TA
J Immunol; 1990 Feb; 144(4):1169-76. PubMed ID: 2303704
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets.
Silverstone AE; Frazier DE; Fiore NC; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):248-59. PubMed ID: 7516097
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice.
DeVito MJ; Thomas T; Martin E; Umbreit TH; Gallo MA
Toxicol Appl Pharmacol; 1992 Apr; 113(2):284-92. PubMed ID: 1561637
[TBL] [Abstract][Full Text] [Related]
7. Prothymocyte activity is reduced by perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Fine JS; Gasiewicz TA; Fiore NC; Silverstone AE
J Pharmacol Exp Ther; 1990 Oct; 255(1):128-32. PubMed ID: 2213547
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2.
Laiosa MD; Lai ZW; Thurmond TS; Fiore NC; DeRossi C; Holdener BC; Gasiewicz TA; Silverstone AE
Toxicol Sci; 2002 Sep; 69(1):117-24. PubMed ID: 12215665
[TBL] [Abstract][Full Text] [Related]
9. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development.
Silverstone AE; Frazier DE; Gasiewicz TA
Exp Clin Immunogenet; 1994; 11(2-3):94-101. PubMed ID: 7826670
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor.
Laiosa MD; Wyman A; Murante FG; Fiore NC; Staples JE; Gasiewicz TA; Silverstone AE
J Immunol; 2003 Nov; 171(9):4582-91. PubMed ID: 14568932
[TBL] [Abstract][Full Text] [Related]
11. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells.
Staples JE; Murante FG; Fiore NC; Gasiewicz TA; Silverstone AE
J Immunol; 1998 Apr; 160(8):3844-54. PubMed ID: 9558089
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diethylstilbestrol affect thymocytes at different stages of development in fetal thymus organ culture.
Lai ZW; Fiore NC; Gasiewicz TA; Silverstone AE
Toxicol Appl Pharmacol; 1998 Apr; 149(2):167-77. PubMed ID: 9571985
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7, 8-tetrachlorodibenzo-p-dioxin.
Staples JE; Fiore NC; Frazier DE; Gasiewicz TA; Silverstone AE
Toxicol Appl Pharmacol; 1998 Jul; 151(1):200-10. PubMed ID: 9705904
[TBL] [Abstract][Full Text] [Related]
14. Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice.
Murante FG; Gasiewicz TA
Toxicol Sci; 2000 Apr; 54(2):374-83. PubMed ID: 10774819
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): an (immuno)histological study.
De Waal EJ; Schuurman HJ; Loeber JG; Van Loveren H; Vos JG
Toxicol Appl Pharmacol; 1992 Jul; 115(1):80-8. PubMed ID: 1631898
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture.
Lai ZW; Fiore NC; Hahn PJ; Gasiewicz TA; Silverstone AE
Toxicol Appl Pharmacol; 2000 Oct; 168(1):15-24. PubMed ID: 11000096
[TBL] [Abstract][Full Text] [Related]
17. Weanling female Sprague-Dawley rats are not sensitive to the antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
White TE; Rucci G; Liu Z; Gasiewicz TA
Toxicol Appl Pharmacol; 1995 Aug; 133(2):313-20. PubMed ID: 7645028
[TBL] [Abstract][Full Text] [Related]
18. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium.
Greenlee WF; Dold KM; Irons RD; Osborne R
Toxicol Appl Pharmacol; 1985 Jun; 79(1):112-20. PubMed ID: 2996175
[TBL] [Abstract][Full Text] [Related]
19. Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in the female rat uterus.
Romkes M; Safe S
Toxicol Appl Pharmacol; 1988 Mar; 92(3):368-80. PubMed ID: 2832970
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in diethylnitrosamine-initiated ovariectomized rats implanted with subcutaneous 17 beta-estradiol pellets.
Wyde ME; Seely J; Lucier GW; Walker NJ
Toxicol Sci; 2000 Apr; 54(2):493-9. PubMed ID: 10774832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
